DERMIRIT CREMA 20G 0.5%

DERMIR

active ingredients

100 g of cream contain: Active ingredient: Hydrocortisone Acetate mg 500.

Excellent

100 g cream contain: palmito stearate of hetilenglycol and polyethyleneglycol g. 20; glycerides polyxyethylene g. 3; vaseline oil g. 3; butylhydroxyanionly g. 0.008; benzoic acid g. 0.200, purified water q.b. 100.

Therapeutic indications

Symptomatic treatment of itching, eczema, insect bites, erythems and circumscribed burns.

Contraindications

It is contraindicated in case of hypersensitivity to product components and other corticosteroids. The use of hydrocortisone is contraindicated in the case of viral, bacterial and fungal diseases. Not to be used in itching vulvare, if associated with vaginal losses. Do not use in children under two years and pregnant, except on prescription and under medical supervision.

Population

Spread in minimum quantity the cream on the sick part and fry slightly, twice a day. Do not exceed the recommended doses. In case you intend to resort to occlusive bandage you carefully deter the part to be treated before each application not to favor the establishment of infections.

Conservation

Protect from heat.

Warnings

Only for external use. Do not apply on extended surfaces. In infants and children the diaper can act as an occlusive bandage, increasing the absorption of the product. The cream does not find ophthalmological use, nor should it be applied in the periocular areas. Do not use for protracted treatments. After a short period of treatment without appreciable results or if conditions worsen, stop applications and consult a doctor. Prolonged use of topical products may lead to irritation or sensitization. In this case interrupt and consult the doctor in order to establish suitable therapy. Keep the medicine out of reach of children.

Interactions

They are not known incompatibility and interactions with other medicines used on a topical basis.

Effects

If the product, contrary to what is prescribed, is used on extended surfaces and for long periods of time and at high doses, more serious signs of local intolerance or signs and symptoms of systemic absorption may occur. Talora may occur locally: sense of burning, irritation, dryness of the skin, follicles, acne eruptions, hypertricosis, hypopigmentation, skin atrophy.

Overdosing

If extensive skin surfaces are treated, especially with occlusive bandage, please note the possibility of systemic effects from corticosteroid reabsorption.

In pregnant and breastfeeding women the product should only be administered in case of actual need and under the direct control of the doctor.

Source: Farmadati